Fermenta Biotech Limited (BOM:506414)

India flag India · Delayed Price · Currency is INR
369.50
-25.50 (-6.46%)
At close: Jul 7, 2026
Market Cap10.87B +8.4%
Revenue (ttm)5.25B +11.9%
Net Income717.65M -6.6%
EPS24.51 -7.0%
Shares Out 29.43M
PE Ratio15.08
Forward PEn/a
Dividend3.75 (0.95%)
Ex-Dividend DateAug 5, 2026
Volume33,093
Open392.00
Previous Close395.00
Day's Range366.00 - 392.00
52-Week Range256.40 - 401.20
Beta-0.23
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About Fermenta Biotech

Fermenta Biotech Limited, together with its subsidiaries, manufactures and markets chemicals, bulk drugs, and enzymes in India, Europe, the United States, and internationally. It provides pharmaceutical formulations and environmental solutions; rents and sells properties; and sports and health awareness/education services. The company also offers various variants of vitamin D3, including crystalline oil, resin oil, cold water dispersible, and feed grade powder for use in various applications, such as pharmaceuticals, dietary and nutritional sup... [Read more]

Industry Pharmaceutical Preparations
Founded 1951
Employees 606
Stock Exchange Bombay Stock Exchange
Ticker Symbol 506414
Full Company Profile

Financial Performance

In fiscal year 2026, Fermenta Biotech's revenue was 5.25 billion, an increase of 11.92% compared to the previous year's 4.69 billion. Earnings were 717.65 million, a decrease of -6.63%.

Financial Statements